Mitsubishi Tanabe Pharma to be removed from Nikkei 300

    Stock will also be deleted from Nikkei 500 and JPX-Nikkei Index 400

    TOKYO -- Nikkei Inc. will delete Mitsubishi Tanabe Pharma as a component of the Nikkei Stock Index 300 due to its designation as "a stock to be delisted" by the Tokyo Stock Exchange. Mitsubishi Tanabe Pharma will be removed on Jan. 20 and replaced by package delivery group SG Holdings on Jan. 22.

    Sponsored Content

    About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.